MapLight Therapeutics, Inc. (MPLT) Capital expenditures 2024–2025
MapLight Therapeutics, Inc. (MPLT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$473,000FY2025 · since FY2024: $770,000 → $473,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $473,000 | -38.6% |
| FY2024 | $770,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice